Company intelligence / Profile preview

Alpha Seven Therapeutics

Dallas, Texas, United States

Ownership: Private
Employees: ~30
Development stage: Other

Overview

Alpha Seven Therapeutics is a privately held neuro-focused biopharmaceutical company created to develop ALPHA-1062IN, an intranasal small-molecule prodrug of benzgalantamine licensed worldwide from Alpha Cognition for cognitive impairment associated with mild traumatic brain injury; it is preparing additional toxicology and manufacturing work to support an IND and subsequent Phase 2 trial, but no human clinical data have yet been reported.[1][2][6]

Therapeutic areas: Neurology
Modalities: Small molecule
Industry: Biotech

Partnerships

Alpha Cognition (exclusive worldwide license for ALPHA-1062IN in traumatic brain injury and related disorders)[1][2][6]United States Department of Defense / U.S. Army Medical Research and Materiel Command grant-supported preclinical study using ALPHA-1062IN for blast mTBI (conducted with Alpha Cognition and Seattle Institute of Biomedical and Clinical Research, but directly relevant to Alpha Seven’s lead asset)[2]

Beyond the preview

Go deeper on Alpha Seven Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha Seven Therapeutics.

Explore the full profile